A series of 5-(benzo [d] [1,3]dioxol-5-yl)-3-tert-butyl-1-substituted-4,5-dihydropyrazole derivatives 4a-e and 6a-g have been synthesized and spectrally characterized. The antibacterial activity of the novel candidates has been screened using the agar diffusion test. These compounds were endowed with high antibacterial activity against different Gram +ve and Gram Àve bacteria when compared with standard antibacterial drugs. In the light of zone of inhibition and MIC results, Sarcina and Staphylococcus aureus are the most sensitive bacteria where pyrrolidinomethanone derivative 4e showed MICs at 80 and 110 nM, respectively. While hydroxypiperidinoethanone derivative 6c showed MIC at 90 nM for Sarcina.
Introduction
Recently, after years of misuse and overuse of antibiotics, potential global health crisis has become very apparent due to remarkable increase in bacterial resistance (Kathiravan et al., 2012) which has been firmly correlated to higher rates of morbidity and mortality (Ozdemir et al., 2007) . In order to overcome such resistance new antibacterial candidates have to be introduced that consist of chemical features which differ from those of the present drugs. Thus, these leads have to be novel nevertheless resemble known biologically active molecules by the presence of critical pharmacophoric structural moieties. This impetus led to innovative heterocyclic permutations with unique action or diverse function. Also, it could be achievable via using small heterocyclic molecules which are highly functionalized scaffolds and are well known pharmacophores incorporated in a great number of molecules characterized by antibacterial activity.
During discovery of novel antibacterial agents, powerful activity has been displayed by natural molecules containing the 1,3-benzodioxole system for example protopine and egonol (Emirdag-Ozturk et al., 2011) and also by several chemically synthesized antimicrobial candidates such as compounds I and II (Chimenti et al., 2011; Wani et al., 2011; Secci et al., 2012) (Fig. 1) .
2-Pyrazoline is a ubiquitous small heterocyclic pharmacophore in medicinal chemistry. Many pharmacological activities have been reported for various 2-pyrazolines such as hypoglycemic (Cottineau et al., 2002) , analgesic , anti-inflammatory (Chakrabarthi et al., 1987) , antitumor (Rostom et al., 2003) , antibacterial (Akbas and Berber, 2005) , and antifungal activities (Akbas and Berber, 2005) . In particular pyrazoline-methanones (e.g. compound III) and pyrazoline-ethanones (e.g. compound IV) have shown an intense antimicrobial potency against TB and several candida species (Mamolo et al., 2001 (Mamolo et al., , 2003 (Fig. 2) .
On the other hand, alicyclic amines occur widely in drugs (Gorrod and Aislaitner, 1994) . Many of these amines such as piperidine and morpholine fostered the antimicrobial activity of chemically synthesized candidates (Qing et al., 2010; Sangshetti et al., 2011) . These amines are susceptible to metabolism giving rise to diverse end products. Noteworthy, one of the most common metabolic pathways of alicyclic amines is acarbonyl formation leading to lactam structures (Gorrod and Aislaitner, 1994) which are well known pharmacophores in antibacterial agents ( Fig. 3) .
Thus it was of interest to implement the symbiotic approach in drug design (Baldwin et al., 1979; Christiaans and Timmerman, 1996) to synthesize novel candidates by joining the benzodioxolpyrazoline moiety with different alicyclic amines via methanone or ethanone linker in order to screen their antibacterial potentials.
Materials and methods

Chemistry
All melting points were determined using an Electrothermal Capillary melting point apparatus and are uncorrected. Infrared (IR) spectra were recorded as thin film (for oils) in NaCl discs or as KBr pellets (for solids) with a JASCO FT/IR-6100 Spectrometer (Japan) and values are represented in cm À1 . 1 H NMR (500 MHz) and 13 C NMR (125 MHz) spectra were recorded on a Jeol ECA 500 MHz spectrometer (Japan) using TMS as internal standard and chemical shift values were recorded in ppm on the d scale. Silica gel TLC (thin layer chromatography) cards from Merck (silica gel precoated aluminium cards with fluorescent indicator at 254 nm) were used for thin layer chromatography. Visualization was performed by illumination with UV light source (254 nm). Column chromatography was carried out on silica gel 60 (0.063-0.200 mm) obtained from Merck. The mobile phase consisted of chloroform or chloroform/ethyl acetate 1/1 v/v. Tetracycline, gentamicin and ofloxacin standard antibiotic discs were purchased from BioanalyseÒ, Turkey.
The Aboul-Enein method has been followed to afford light brown solid mp 37°C.
2.1.2. Synthesis of (1E)-1-(1,3-benzodioxol-5-yl)-4,4dimethylpent-1-en-3-one (2) (Aboul-Enein et al., 2012; Vallet, 1975) The Aboul-Enein method has been followed to afford 13 g (78%) of 2 as pale yellow crystals mp 92°C.
2.1.3. Synthesis of 5-(1,3-benzodioxol-5-yl)-3-tert-butyl-4,5dihydro-1H-pyrazole (3) (Aboul-Enein et al., 2012) Hydrazine hydrate (0.62 mL, 0.64 g, 0.012 mol) was added to a solution of 2 (1.0 g, 0.0043 mol) in absolute ethanol (30 mL). The reaction mixture was stirred under reflux for 2 h, and evaporated under vacuum to afford 1.0 g (90%) of 3 as yellowish oil. 1 H-NMR (CDCl 3 ): 1.0 (s, 9H, t-butyl), 2.3 (dd, J = 10.7, 16.1 Hz, 1H, CHCH 2 ), 2.9 (dd, J = 9.95, 16.1 Hz, 1H, CHCH 2 ), 4.5 (t, J = 9.9, 10.7 Hz, 1H, CHCH 2 ), 5.9 (s, 2H, O-CH 2 -O), 6.7 (s, 1H, NH), 6.75 (dd, J = 1.5, 7.6 Hz, 1H, H-6), 6.7 (d, J = 8.4 Hz, 1H, H-7), 6.8 (s, 1H, H-4) ppm. 13 C NMR (CDCl 3 ) of 3 (base): 27.9 (C(CH 3 ) 3 ), 35.5 (C(CH 3 ) 3 ), 40.0 (CHCH 2 ), 60.0 (CHCH 2 ), 101 (OCH 2 O), 107, 108, 120 (CH ar ), 137 (C ar ), 146, 147 (C ar ), 160 (C‚N) ppm.
2.1.4. General procedures for synthesis of (5-(benzo[d] [1, 3] dioxol-5-yl)-3-tert-butyl-4,5-dihydropyrazol-1yl)(heteroalicyclic)methanones (4a-e)
To a stirred solution of 3 (0.5 gm, 2 mmol) in 20 ml CHCl 3 , phosgene (12.5% W/V solution in toluene, 1.6 ml, 2 mmol) was added. The mixture was stirred at room temperature for 10 min followed by the addition of the appropriate amine (6 mmol, 3 mol equivalents). The reaction mixture was kept under stirring at room temperature overnight then washed with NaHCO 3 (10%, 20 ml), water and the organic layer was separated, dried (Na 2 SO 4 ), and evaporated under vacuum to afford the corresponding products 4a-e. Solid products were further purified by recrystallization from ethanol while oils by column chromatography. 
Yellow oil, yield 90%; IR (thin film, cm À1 ): 1648 (C‚O), 1455 (C‚N). 1 H NMR (CDCl 3 ): d 1.0 (t, J = 6.9, 6.85 Hz, 3H, CH 3 CH 2 ) 1.1 (s, 9H, t-butyl), 2.32-2.45 (m, 6H, CH 3 CH 2 & H for piperazine), 2.55 (dd, J = 5.4, 17.6 Hz, 1H, CHCH 2 ), 3.15 (dd, J = 5.35, 16.8 Hz, 1H, CHCH 2 ), 3.7 (t, J = 6.9, 5.53 Hz, 4H, H for piperazine), 5.2 (t, J = 11.45, 9.2 Hz, 1H, CHCH 2 ), 5.9 (s, 2H, O-CH 2 -O), 6.7-6.8 (m, 3H, H aromatic) ppm. 13 C NMR (CDCl 3 ): d 12 (CH 3 ), 28 (C(CH 3 ) 3 ), 34 (C(CH 3 ) 3 ), 41 (CHCH 2 ), 45 (CH 2 ), 52 (C for piperazine), 53 (C for piperazine), 62 (CHCH 2 ), 101 (O-CH 2 -O), 106, 108, 120, 137, 147, 148 (CH ar To a stirred solution of 3 (0.5 g, 2 mmol) in 20 ml CHCl 3 , chloroacetyl chloride (0.16 ml, 0.23gm, 2 mmol) was added. The mixture was stirred at room temperature for 30 min then the reaction mixture was washed with NaHCO 3 (10%, 20 ml) and the organic layer was separated, dried (Na 2 SO 4 ), and evaporated under vacuum to afford crude 5. Crystallization from ethanol afforded 0.6 g (100%) of yellowish white solid mp 172°C. To a stirred solution of 5 (0.5 gm, 1.5 mmol) in 30 ml ethanol, the appropriate alicyclic amine (4.5 mmol) was added and the mixture was stirred under reflux overnight. The solvent was evaporated under reduced pressure and the residue was dissolved in ethyl acetate, washed with NaHCO 3 (10%, 20 ml) then water, dried (Na 2 SO 4 ), and evaporated under vacuum to afford the corresponding products 6a-g. Solid products were further purified by recrystallization from ethanol while oils by column chromatography (silica gel 60 (0.063-0.200 mm) mobile phase: chloroform 100% or chloroform/ethyl acetate 1/1 v/v). 2.1.6.3. 1-(5- (Benzo[d][1,3 ]dioxol-5-yl)-3-tert-butyl-4,5-dihydropyrazol-1-yl)-2-(4-hydroxypiperidin-1-yl)ethanone (6c). Yellowish liquid; yield 80%; IR (thin film, cm À1 ): 3406 (OH), 1651 (C‚O), 1453 (C‚N). 1 H NMR (CDCl 3 ): d 1.0 (s, 9H, t-butyl), 1.45 (d, J = 9.2 Hz, 2H, H for piperidine), 1.6 (s, 2H, H for piperidine), 2.1 (d, J = 9.9 Hz, 2H, N-(CH 2 ) 2 for piperidine), 2.55 (d, J = 18.35 Hz, 1H, CHCH 2 ), 2.7 (d, J = 12.25 Hz, 2H, N-(CH 2 ) 2 for piperidine), 3.1 (m, 1H, CHCH 2 ), 3.4-3.6 (m, 4H,CHOH, COCH 2 N), 5.1 (d, J = 11.45 Hz, 1H, CHCH 2 ), 5.8 (s, 2H, O-CH 2 -O), 6.4-6.6 (m, 3H, H aromatic) ppm. 13 C NMR (CDCl 3 ): d 28 (C(CH 3 ) 3 ), 34 ((CH 2 ) 2 CHOH for piperidine), 34.1 (CHCH 2 ), 41 (C(CH 3 ) 3 ), 51 (N-(CH 2 ) 2 for piperidine), 58 (COCH 2 N),59 (CHCH 2 ), 67 (CHOH), 101 (O-CH 2 -O), 105, 108, 118, 136, 146, 147 (CH ar 2.1.7. General procedures for synthesis of (5-
To a stirred solution of 5 (0.5 g, 1.5 mmol) in 30 ml ethanol, the appropriate alicyclic amine (4.5 mmol) was added followed by NaOH (0.06 g, 1.5 mmol). The mixture was stirred under reflux overnight then the solvent was evaporated under reduced pressure and the residue was dissolved in ethyl acetate, washed with NaHCO 3 (10%, 20 ml) then water, dried (Na 2 SO 4 ), and evaporated under vacuum to afford the corresponding products 6d-f which were further purified by recrystallization from ethanol. 2.1.7.2. 1-(5- (Benzo[d] [1,3]dioxol-5-yl)-3-tert-butyl-4,5-dihydropyrazol-1-yl)-2-(pyrrolidin-1-yl)ethanone (6e). Yellowish white solid, mp 134-136°C; yield 81%. IR (KBr, cm À1 ): 1670 (amide, C‚O), 1485 (C‚N). 1 H NMR (CDCl 3 ): d 1.0 (s, 9H, t-butyl), 1.7 (m, 4H, H for pyrrolidine), 2.65 (m, 5H, CHCH 2 , (N-(CH 2 ) 2 ) for pyrrolidine), 3.2 (dd, J = 11.45, 17.55 Hz, 1H, CHCH 2 ), 3.6 (dd, J = 16.8, 16.8 Hz, 2H, COCH 2 N), 5.3 (dd, J = 3.85, 11.5 Hz, 1H, CHCH 2 ), 5.9 (s, 2H, O-CH 2 -O), 6.5-6.7 (m, 3H, H aromatic) ppm. 13 C NMR (CDCl 3 ): d 23, 28 (C(CH 3 ) 3 ), 34 (CHCH 2 ), 41 (C(CH 3 ) 3 ), 54 (N-(CH 2 ) 2 ) for pyrrolidine), 57 (COCH 2 N), 59 (CHCH 2 ), 101 (O-CH 2 -O), 105, 108, 119, 136, 146, 148 (CH ar 
Antibacterial assay
Antibacterial activities of compounds 4a-e and 6a-g were tested using the agar well diffusion method. The concentration of the microbial suspensions was adjusted to 0.5 McFarland standards. The bacterial suspensions were seeded on nutrient agar plates. In each of these plates many wells were cut using a sterilize cork borer. Using a micropipette, 200 lL of sample was added into different wells. A positive control antibiotic disc was placed in the plate. Bacterial plates were incubated for 24 h at 37°C. Antimicrobial activity was evaluated by measuring the zone of inhibition.
Results and discussion
Chemistry
The synthesis of the target compounds 4a-e and 6a-g, and their intermediates 1-3 and 5 is depicted in Schemes 1 and 2.
Piperonal (1) (Aboul-Enein et al., 2012; Nakatani et al., 1977) was obtained by reacting 3,4-dihydroxybenzaldehyde with CH 2 Cl 2 in the presence of K 2 CO 3 under reflux conditions. Subsequent Claisen-Schmidt condensation with pinacolone afforded a,b-unsaturated ketone 2 in good yield. Chalcone 2 was reacted with hydrazine hydrate in ethanol under reflux conditions to yield pyrazoline derivative 3 (Aboul-Enein et al., 2012) (Scheme 1).
Key pyrazoline 3 was further reacted with phosgene at room temperature to afford the carbamoyl chloride intermediate which was -in the same pot -reacted with the appropriate amine to afford pyrazolinemethanones 4a-e (Scheme 2). On the contrary, the intermediate pyrazoline chloroethanone 5 was stable enough to be isolated after the reaction of pyrazoline 3 with chloroacetyl chloride in CHCl 3 at room temperature. Further reaction of 5 with different alicyclic amines in ethanol under reflux gave the target compounds 6a-c and 6g.
For compounds 6d-f the reaction was performed in the presence of 1 mol equivalent of NaOH (Scheme 2).
The spectral data of the synthesized compounds were investigated. The 1 H NMR spectra of a,b-unsaturated ketone 2 showed the olefinic protons as doublet of doublet at d 6.1 and doublet at d 6.5 with coupling constant J = 15.3 which indicates trans geometric isomerism and it was in accordance with the assigned structure and the reported data (Aboul-Enein et al., 2012) . For pyrazoline 3, 1 H NMR spectra showed two doublet of doublet signals at 2.3 and 2.9 ppm corresponding to the prochiral CH 2 protons while CH proton responded as triplet signal at 4.5 ppm. One singlet signal at 6.7 ppm was found corresponding to the NH proton at position 1 of the pyrazoline ring. In addition, singlet signals were found at 1.0 and 5.9 ppm for t-butyl and the ethereal methylene bridge protons, respectively. The aromatic protons were elucidated at 6.4-6.8 ppm. 1 H NMR spectra of pyrazolinechloroethanone 5 revealed the characteristic signals of 3 in addition to the singlet signal corresponding to the methylene protons at d 4.4. However in the final products 6f and 6e, methylene protons were magnetically un-equivalent and displayed as doublet of doublet signals at d 4.4 for 6f and d 3.6 for 6e with identical coupling constant. For 13 C NMR, the urea carbonyl of 4a-e was elucidated at 156-157 ppm while the amidic carbonyl of 6a-g was elucidated at 165-167 ppm. 
